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Wednesday, February 24, 2010 717asize was markedly smaller in ILP (1953%,n=8) compared to CTRL
(55.653.4%,n=10). The inhibition of mitochondria permeability transition
pore (mPTP) opening during reperfusion has been shown to induce cardiopro-
tection. To investigate whether intralipid-induced cardioprotection occurs by
inhibition of the mPTP opening, we compared the viability of isolated mito-
chondria by calcium overload. Postischemic administration of Intralipid in-
hibited the opening of the mPTP as calcium retention capacity was higher in
the ILP group compared to control (2.750.06 vs. 1.550.11 mM/mg-mitochon-
drial protein, p<0.05). To identifiy the key signaling molecules involved in reg-
ulating mPTP opening, Western Blot analyis of heart lysates was performed.
The activity of AKT/ERK1/GSK were respectively 2.3, 5 and 2.7 fold higher
in ILP compared to CTRL. The involvement of PI3K/AKT pathway was further
investigated by LY294002, a specific inhibitor of PI3K. The Intralipid-induced
cardioprotection was fully abolished in the presence of LY294002, indicating
the cardioprotective action of Intralipid is mediated via PI3K/AKT pathway.
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The proteasome is the major protein degradation system in the heart, and its ac-
tivity has been shown to be affected during pathological cardiac diseases. Pro-
teasome dysfunction in the hypertrophic heart leads to accumulation of abnor-
mal proteins and has been proposed to contribute to the transition to heart
failure. Pregnancy places an increased demand on the healthy female’s heart
resulting in ventricular hypertrophy and diastolic dysfunction as a result of vol-
ume overload and increased stretch and force demand. Since the molecular sig-
nature of pregnancy-related heart hypertrophy differs significantly from that of
pathological hypertrophy, we investigated if the proteasome proteolytic path-
way is affected by pregnancy in the mouse heart. We measured the transcripts
and protein levels of proteasome subunits as well as proteasome activity in four
groups of female mouse hearts: i) non pregnant (NP) at diestrus stage, ii) late
pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum
(PP7). Real Time PCR showed that the transcript levels of RPN2 and RPT4
(subunits of 19S) as well as b2 and a7 (subunits of 20S) did not change with
pregnancy. Western blot analysis of heart lysates also revealed no significant
differences in the expression levels of a7 (a subunit of 20S), RPN2 and
RPT4 (subunits of 19S) subunits in the four groups mentioned above. The b1
(caspase-like) and b2 (trypsin-like) activities of the proteasome were signifi-
cantly decreased in LP. The b5 (chymotrypsin-like) activity was significantly
decreased 1 day post-partum. Interestingly, all three proteolytic activities of
the proteasome were restored to normal levels 7 days post-partum. These re-
sults suggest that the proteasome proteolytic pathway is affected by pregnancy
and is restored to NP levels soon after delivery.
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Septic cardiomyopathy is an acute cardiac syndrome that occurs after the onset
of sepsis due to infectious agents such as bacteria, viruses and fungi. During sep-
tic cardiomyopathy cardiac output falls due to waning contractile function of the
heart. However, very little is known about the precise cause of cardiac failure in
cases of sepsis. One factor induced during sepsis is the complement activation
product C5a. C5a is a peptide that acts through a G-protein coupled receptor
(C5aR) and affects cardiac myocyte contractility by unknown mechanisms.
Here we have tested the effect of C5a peptide on single adult cardiac myocyte
calcium homeostasis. Cardiac myocytes were isolated from healthy rats and in-
tracellular calcium transients were monitored (fluo-4AM) before and after C5a
peptide treatment. Intracellular calcium was monitored by two different
methods: 1) using a conventional photomultiplier tube and, 2) using a high speed
digital CCD camera (200frames/s) to image whole cell calcium transients and
waves. Recombinant C5a was applied to cardiac myocytes during electrical pac-
ing (0.5Hz, 40V). After application of C5a (82ng/mL) intracellular calcium con-
centrations and calcium transient amplitudes initially rose (from F/
Fo=1.4350.12 to 1.8650.4, n=4). Calcium transient duration was also pro-
longed after C5a addition (half width=260.2529.0 ms to 318.7547.1ms) and
spontaneous calcium transients and waves were observed in the diastolic period
between electrical stimuli. Consequently the amplitude of calcium transients
and contractions varied from stimulated beat to beat after C5a addition. Para-
doxically at higher pacing frequencies (3Hz) calcium transient amplitude was
smaller after C5a application (F/Fo=1.4650.2 vs. 1.3250.04, n=4) and pro-longed (half width=127.051.15 vs. 167.0515.6 ms). Spontaneous calcium
transients were also observed in the absence of electrical stimulation following
C5a treatment. These data suggest that C5a peptide acts through its receptor
C5aR to cause cardiac myocyte intracellular calcium overload.
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Diabetes mellitus is often associated with abnormalities in active relaxation and
passive stiffness of the left ventricle but the molecular mechanisms responsible
for the dysfunction are not yet clear. This study was designed to identify the
molecular components that are responsible for the increased myocardial stiff-
ness associated with diabetes. Multicelluar myocardial preparations were iso-
lated from control Sprague-Dawley rats and an experimental group of rats in-
jected 4 weeks previously with streptozotocin (model of Type I Diabetes).
Preparations were subjected to paired ramp stretches/releases imposed under
fiber length control in a series of calcium activations (pCa 4.5 - 9.0). The rel-
ative short-range force and elastic limits were substantially higher in the dia-
betic groups. The rate of tension recovery (ktr) was considerably lower in the
diabetic groups. Short range stiffness values did not differ in the control and
diabetic animals. Gel electrophoresis showed that the relative content of slower
beta Myosin heavy chain increased
from 34515% in control hearts to
100% in the diabetic rat hearts. These
results support the hypothesis that
pathological changes in the mechani-
cal properties of diabetic rat myocar-
dium are mostly due to alterations in
the active component (cycling cross-
bridges) of ventricular stiffness.3731-Pos
Increased Phosphorylation of Myofilament Proteins after Stretch in
Rabbit Ventricular Myocardium
Michelle M. Monasky, Paul M. L. Janssen.
The Ohio State University, Columbus, OH, USA.
After a change in muscle length, there is an immediate intrinsic response in the
amount of developed force, followed by a slower response. Although it has been
well documented that the slow force response is at least in part generated by
modification of calcium handling, it is unclear whether regulation at the level
of the myofilaments occurs during the slow force response. We set out to inves-
tigate myofilament calcium sensitivity and phosphorylation status of myofila-
ment proteins after a step-wise change in cardiac muscle length. Ultra-thin right
ventricular intact trabeculae were isolated from New Zealand White rabbit
hearts and iontophoretically loaded with the calcium indicator bis-fura-2.
Twitch force-calcium relationships and steady state force-[Ca2þ]i relationships
were measured at slack and optimal muscle lengths at 37C using potassium in-
duced contractures. The EC50 significantly decreased with increase in muscle
length, from 14675271 nM at the shortest muscle length to 6535121 nM at
the longest muscle length. Maximal active force development significantly in-
creased from 19.752.7 mN/mm2 at the shortest muscle length to 51.855.0
mN/mm2 at the longest muscle length. No significant change in the myofilament
cooperativity coefficient was found. Phosphoprotein analysis using ratiometric
analysis of Pro-Q diamond staining and Sypro-Ruby staining of the same gel,
revealed increased phosphorylation of tropomyosin, troponin I, and myosin light
chain-2 at longer muscle lengths. Since the immediate response is seen virtually
instantaneously, and post-translational modifications cannot occur within that
timeframe, we hypothesize that these increases in phosphorylation occur during
the slow response. Future studies will aim to elucidate the individual effects of
the immediate response verses post-translational modifications during the slow
response, and also determine to what extent increased phosphorylation of tropo-
myosin, troponin I, and myosin light chain-2 each play a role.
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718a Wednesday, February 24, 2010Drosophila melanogaster possess a simple linear heart tube and constitute an
excellent genetic model system with which to investigate the effects of cardi-
omyopathic mutation. The Mhc5 myosin heavy chain mutation is located in the
‘transducer’domain and elicits hypercontractile function at the molecular level
characterized by high ATPase activity and enhanced in vitro motility proper-
ties. Additionally, its expression impairs diastolic relaxation of the cardiac
tube reminiscent of restrictive cardiomyopathy in humans. We have investi-
gated the effect of the Mhc5 mutation on cardiac structure/function by quanti-
tative proteomics using isobaric tags for relative quantification (iTRAQ). Ex-
cised fly hearts from yw (control) and Mhc5 strains were digested with
trypsin, reduced, alkylated and labeled with ITRAQ reagent. Peptides from
each pool were mixed together prior to fractionation by strong cation exchange
chromatography and subsequent reversed-phase HPLC coupled to tandemmass
spectrometry. This approach identified approximately 600 proteins, of which
94 were upregulated and 86 were downregulated in Mhc5 hearts relative to
yw hearts (p<0.05). Ontological cluster analysis of the genes encoding the reg-
ulated proteins revealed that myofibrillar disarray in Mhc5 hearts likely stems
from overexpression of actin with concomitant reduction of myofibrillar assem-
bly proteins such as spectrin, and other actin-binding proteins. Structural re-
modeling was also characterized by increased expression of extracellular ma-
trix proteins. Upregulation of proteins involved in mitochondrial oxidative
phosphorylation and fatty acid catabolism suggests further bioenergetic remod-
eling. The proteomic, structural and ultrastructural data are consistent with
a model whereby the elevated ATPase activity caused by Mhc5 mutation in-
creases energetic demand, thereby stimulating a concerted compensatory met-
abolic response to maintain energetic homeostasis. Ongoing protein-network/
interactome analysis will help to further refine the model.
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Possible therapeutic benefits of stem cell treatments have been widely investi-
gated recently. We have presented initial reports that co-culturing mesenchy-
mal stem cells (MSC, Lonza) with rat heart cells in primary culture can prevent
the consequences of the treatment with a inflammatory bacterial endotoxin
(LPS, Lipopolysaccharide-A). We now investigate how the MSC produce their
beneficial actions. Using sparse primary cultures of neonatal rat ventricular or
adult rat ventricular myocytes with either MSC or control cells (fibroblasts), we
examine cardiac Ca2þ signaling. LPS causes Ca2þ signaling anomalies which
include delayed afterdepolarizations (DADs) and Ca2þ-enhanced early afterde-
polarizations (EADs). We find that co-cultures with cells co-mingled can pre-
vent the untowards actions of LPS on the cardiac myocytes. The negative con-
sequences of LPS are alterations in the normal [Ca2þ]i transient that is
stimulated by field shocks as described above. Since the benefit of MSC co-cul-
ture are found even when a solute per-
meable / cell impermeant membrane
separates the MSC from the LPS
treated cardiac myocytes, we con-
clude that a paracrine action of the
MSC can account for the treatment at-
tributed to the MSCs. We continue to
investigate possible beneficial signal-
ing pathways that may explain the
paracrine effect of MSCs.3734-Pos
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Cell-based cardiac repair following myocardial infarction has gained consider-
able interest recently, and the human pluripotent stem cell is an attractive cell
source due its efficient differentiation into immature but functional cardiomyo-
cytes. We examined the biophysical characteristics of cardiomyocytes gener-
ated from human embryonic stem cells (hESC-CMs) by measuring calcium
transients, single cell contractions, and actomyosin interactions via flash pho-
tolysis. Furthermore, we compared these characteristics with those obtained
from a second promising but still poorly characterized cell type, the human in-duced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM). We hypothe-
sized that understanding fundamental biochemical and mechanical characteris-
tics of these cells would provide insight into potential strategies to induce
further cell maturation in vitro.
Our results suggest that hESC-CMs and hiPSC-CMs exhibit spontaneous con-
tractions and calcium transients with similar kinetics, including time to peak
[Ca2þ]i (116534ms vs. 155540ms) and time to 50% [Ca
2þ]i decay
(352587ms vs. 296549ms). Furthermore, quantitative videomicroscopy of
resulting single cell contractions suggests that cardiomyocytes from both sour-
ces demonstrate similar resting cell size (17.151.4um vs. 16.554.6um), con-
traction amplitude (4.251.6% vs. 4.452.1%), time to peak contraction
(0.34650.135sec vs. 0.33950.214sec), maximum contraction velocity
(6.3453.50um/sec vs. 7.4654.81um/sec), and maximum relaxation velocity
(3.2152.49um/sec vs. 3.4052.49um/sec).
We have also successfully isolated and purified 20 ug of myosin per million
hESC-CMs. Using flash photolysis to liberate ATP in a solution of actomyosin,
we have shown that the myosin binds actin and is dissociated from the complex
by ATP with the expected 2nd order rate constant (~1 uM1sec1).
In summary, the contractile properties of hESC-CMs and hiPSC-CMs are sim-
ilar to each other but differ from values published for adult human cardiomyo-
cytes, suggesting that they are functionally immature and may benefit from
in vitro maturation efforts.
Support appreciated from NIH HL064387/HL080431, NHLBI T32GMO7266-
35S1, and the Wellcome Trust.
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Cellular cardiomyoplasty to replace non-functional tissue following cardiac in-
farction appears clinically viable. Current strategies utilizing direct injection of
cell suspensions are limited by low cell retention, poor cell localization, and
high cell death. Synthetic biomaterials developed to enhance cell delivery
can lead to problems with immune rejection, degradation, and mechanical mis-
match, preventing functional integration of constructs with host myocardium.
The goal of this project is to develop a functional cardiac tissue construct
with enhanced host integration capabilities as a novel strategy to replace dam-
aged myocardium. We have developed a novel templated fibrin scaffold seeded
with cells to promote functional integration. Fibrin is an ideal scaffold material
because it can be autologous, improves cell attachment and growth, and de-
grades into natural byproducts that can induce angiogenesis. The novel scaffold
architecture includes 1) microchannels spanning the length of the scaffold, al-
lowing alignment and organization of cells to mimic native cardiac tissue struc-
ture, and 2) micropores to enhance construct survival by improving nutrient de-
livery and waste removal. The dense fibrin scaffolds (stiffness ¼ 16.0 5 3.0
kPa) had mechanical properties closer to native myocardium than fibrin gels
(0.5 to < 7 kPa). Centrifuge seeding with a tri-cell mixture of cardiomyocytes,
endothelial cells, and fibroblasts increased scaffold stiffness (38.35 8.9 kPa)
to values near neonatal myocardial tissue (~40 kPa). Stiffness decreased over
time in culture (25.25 3.1 kPa, Day 6), which may indicate ECM formation
and scaffold degradation. Patches of beating cells were observed inside chan-
nels within two days in culture. After three days in culture, histology showed
cardiomyocyte and fibroblast alignment and immature lumen formation. These
results indicate micro-templated fibrin scaffolds are a unique and viable plat-
form for cardiac tissue engineering. This work supported by NIH HL064387
(MR, MS, BR) and NSF GRFP (KT).
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The muscle specific protein NRAP plays a role in myofibril assembly and is up-
regulated in mouse models of dilated cardiomyopathy. We sought to determine
if increased N-RAP expression would directly lead to a cardiomyopathy pheno-
type. Novel transgenic lines were developed using the tet-off system with trans-
genic N-RAP expression requiring the tetracycline transactivator (tTA). tTA
was introduced by mating the N-RAP transgenic animals with well-character-
ized animals carrying the tTA transgene controlled by the cardiac specific al-
pha-myosin heavy chain promoter. Multiple founder lines were examined
and lines showing the most significant increase in NRAP expression were
used for further investigation. N-RAP expression in theses animals was up to
2.5 times greater than control littermates as determined by western blot analy-
sis. Histological examination of hearts from ~12 week old transgenic mice
